• 1. School of Nursing Science, Huzhou University, Huzhou, 313000, P.R.China;
  • 2. School of Medicine, Huzhou University, Huzhou, 313000, P.R.China;
  • 3. Health and Family Planning Bureau of Huzhou City, Huzhou, 313000, P.R.China;
  • 4. The First Affiliated Hospital of Huzhou University, Huzhou, 313000, P.R.China;
SHEN Jiantong, Email: sjiantong@163.com
Export PDF Favorites Scan Get Citation

ObjectivesIn order to provide baseline data for the establishment of urban health indicator system in China and other cities, the indicators, characteristics and problems of 24 urban health indicator systems in China were researched.MethodsCNKI, Wan Fang Data, VIP, as well as China’s all provinces and cities’ websites of government and family planning commission and patriotic health campaign commission were searched to collect literatures and government documents on " Healthy city” and its index system. They were then been extracted, classified and summarized.ResultsThe final search involved 24 healthy city indicators system in China, including 1 531 indicators and 14 dimensions, 5 operations and 8 special operations. Seven dimensions (health, health services, environmental health, social indicators, indicators of policy, indicator of health promoting) were widely used. 38 indicators were used above five times, while 441 indicators were used merely once.ConclusionsThe structure of urban health indicator systems in China are almost consistent with WHO’s. They all have the characteristics of diversity, characteristic, national policy, civilian etc. However, there still exists problems with indicators of quantity, definition, classification and lack of indicators on mental health, children health, pregnant woman health as well as elderly health. It is urgent to develop the principles, methods, processes and standards for urban health indicators.

Citation: WEN Qiuyue, LU Dongmin, JIANG Baorong, YAO Jinlan, SHEN Xuhui, SHEN Lijuan, SHEN Jiantong, JIANG Qi, ZHANG Yi. The indicators of healthy cities in China: a systematic review. Chinese Journal of Evidence-Based Medicine, 2018, 18(6): 617-623. doi: 10.7507/1672-2531.201711121 Copy

  • Previous Article

    Febuxostat versus allopurinol in chronic gout treatment: a pharmacoeconomic evaluation
  • Next Article

    The key elements of technological achievements “production-transformation” in China: a systematic review